Prometheus Biosciences

Developer of drugs for gastrointestinal diseases

placeSan Diego, California, United States calendar_todayFounded 2016 groups18 employees language prometheusbiosciences.com

Registered entities

Innovation

52 patent families (20 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities, Operations & transport; filing pace steady. Cited 2,890 times.

YearFilings
20181
20193
202020
20219
202210
202321
202422
202522
20265

Investor mix

11 investors on record; lead investors include Eventide Funds, RTW Investments.

Investor typeCountShare
Venture capital327%
Private equity19%
Accelerator & incubator19%
Bank & private debt19%
Other / undisclosed545%
Coming soon